MMV 8th Call for Proposals for African Scientists: Malaria Drug Discovery
Medicines for Malaria Venture (MMV) welcomes proposals for the Malaria drug discovery grant under the 8th African scientists call for proposals.
Eligibility:
Proposals should be from endemic region African scientists focused in the following priority areas:
- Compounds with confirmed activity on any antimalarial lifecycle stage: Novel molecules with confirmed activity (EC50 < 10uM) and a medicinal chemistry plan that tackles any known or anticipated liability. In line with MMV strategic goals, priority will be given to compounds with potential for optimization as drugs for chemoprevention with a human half-life >120h.
- Assay development and screening: Assay development and screening to support discovery or development of novel antimalarials.
- Computer-aided drug discovery: Use of computational approaches (cheminformatic and/or bioinformatic) to discover new molecules with predicted antimalarial activity or new antimalarial drug targets.
- NEW Innovative biology: Large molecules, biologics or oligonucleotides for the treatment or chemoprevention of malaria.
The proposals funded as part of this call will have a project start date of 1 January 2026.
Read more here.
Application deadline, 29th of August, 2025 at 1200PM (CEST).
